A phase I study of folate immune therapy (EC90 vaccine administered with GPI-0100 adjuvant followed by EC17) in patients with renal cell carcinoma (Q45343606)

From Wikidata
Jump to navigation Jump to search
scientific article published in May 2013
edit
Language Label Description Also known as
English
A phase I study of folate immune therapy (EC90 vaccine administered with GPI-0100 adjuvant followed by EC17) in patients with renal cell carcinoma
scientific article published in May 2013

    Statements

    A phase I study of folate immune therapy (EC90 vaccine administered with GPI-0100 adjuvant followed by EC17) in patients with renal cell carcinoma (English)
    Robert J Amato
    Aditya Shetty
    Yingjuan Lu
    Ron Ellis
    268-275

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit